Physician-based active cost management of oncological therapies reducing pharmaceutical costs by 83.4% in two years without leaving standard of care

Onkologie

Volumn 28, Issue 8-9, 2005, Pages 441-445

  Jacobs, Volker R ^a,b   Thoedtmann, Jutta ^b   Euler, Uta ^a   Paepke, Stefan ^a   Fischer, Thorsten ^a   Harbeck, Nadia ^a   Kiechle, Marion ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER THERAPY; EMPLOYMENT; HEALTH CARE COST; ONCOLOGY; PHYSICIAN; PROSPECTIVE STUDY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COST SAVINGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COSTS; FEMALE; GENITAL NEOPLASMS, FEMALE; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; NATIONAL HEALTH PROGRAMS; OVARIAN NEOPLASMS; PHYSICIAN'S ROLE; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; REIMBURSEMENT MECHANISMS;

EID: 27644512288     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086395     Document Type: Article

References (7)

1. Jacobs VR, Thoedtmann J, Brunner B, Kiechle M: An economic model to reduce the cost of chemotherapy for gynecologic cancer. Int J Fertil Womens Med 2004;49:274-277.
2. Jacobs VR, Thoedtmann J, Brunner B, Kiechle M: Modell eines aktiven Kostenmanagements gynäkoonkologischer Therapien zur Reduktion der Medikamentenkosten um 58.7% innerhalb eines Jahres. Geburtshilfe Frauenheilkd 2005;65:46-55.
3. Gieseking F, Leppek K, Ramthun B, Baehr M, Jänicke F: Finanzierbarkeit gynäkologisch/onkologischer Therapien. Gynakologe 2000;33:508-513.
4. Sozialgesetzbuch V (SGB V). http://bundesrecht.juris.de/bundesrecht/ sgb_5/index.html.
5. Bennett CL, Stinson TJ: Does reimbursement affect physician decision making? Cancer Treat Res 2000;102:137-149.
6. Schoffski O, Graf von der Schulenburg JM: Unintended effects of a cost-containment policy: results of a natural experiment in Germany. Soc Sci Med 1997;45:1537-1539.
7. Jacobs VR: Das aktuelle Bundessozialgerichtsurteil zur Studienfinanzierung: Onkologische Studien in Deutschland vor dem finanziellen Ende? Onkologie 2004;27:589-590.